PRINT THIS PAGE

Healthcare venture capital report 2004

A total of 470 life sciences companies raised $5.8bn in venture capital investment in 2003. The sector increased its share of total venture investment from 26 per cent in 2002 to over 30 per cent last year.

Biotechnology and pharmaceutical companies received seven of the sector's top ten investments and accounted for nearly 60 per cent of all funding. Overall, 226 biotechnology and pharmaceutical companies raised $3.4bn, 144 medical device companies raised $1.4bn, and 80 medical software and services companies raised $832m.

Click here to view the executive summary of this report (pdf 300kb)

You need Adobe Acrobat to read this document. If you do not have it, you can download it free from www.adobe.com/products/acrobat/readstep.html

Growthink Inc. assists high-growth companies with the capital-raising process, specialising in firms seeking between $1m and $20m in equity financing. Growthink believes that preparing a company for operational success is similar to preparing it for financing success. As such, our services combine market research, strategy development and investor communications to achieve these highly correlated goals. Since August 1999, Growthink has worked with over 100 clients, from start-ups to later stage firms. They work with firms across a wide range of technologies, from internet telephony, to wireless commerce, to networking software, to medical devices, to data storage providers, to infrastructure logistics. www.growthinkresearch.com